Anoro Ellipta (Umeclidinium/Vilanterol)

Overview
Anoro Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) as long-term, once-daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary… read more

Aralast NP (Alpha1-proteinase inhibitor [human])

Overview
Aralast NP is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare… read more

Atrovent (Ipratropium bromide)

Overview
Atrovent is a prescription drug approved by the Food and Drug Administration (FDA) for the maintenance treatment of bronchospasms caused by asthma, allergies, chronic obstructive pulmonary disease (COPD), and… read more

Bevespi Aerosphere (Glycopyrrolate/Formoterol fumarate)

Overview
Bevespi Aerosphere is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease… read more

Breo Ellipta (Fluticasone/Vilanterol)

Overview

Breo Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) in 2013 for daily maintenance treatment in cases of chronic obstructive pulmonary disease (COPD). Breo Ellipta helps… read more

Breztri (Budesonide, Glycopyrrolate, and Formoterol fumarate)

Overview
Breztri is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as long-term, daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease… read more

Combivent Respimat (Ipratropium bromide/Albuterol)

Overview
Combivent Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2011 to prevent bronchospasm in people with chronic obstructive pulmonary disease (COPD). Combivent Respimat is… read more

Daliresp (Roflumilast)

Overview
Daliresp is a prescription drug approved by the Food and Drug Administration (FDA) to reduce the risk of exacerbations in people with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and a… read more

Duaklir Pressair (Aclidinium bromide/Formoterol fumarate)

Overview
Duaklir Pressair is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease… read more

Dupixent (Dupilumab)

Overview
Dupixent is approved by the U.S. Food and Drug Administration (FDA) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease (COPD) who have an eosinophilic phenotype (high levels…

Glassia (Alpha1-proteinase inhibitor [human])

Overview
Glassia is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin deficiency, a rare genetic… read more

Incruse Ellipta (Umeclidinium bromide)

Overview
Incruse Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) for long-term, once-daily maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary… read more